Corrigendum to “Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway”

In the article titled “Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway” [1], there was an error in Section 2.5 “Measurement of Serum Biochemical Markers” of the article body. Section 2.5 “Measurement of Serum Biochemical Markers” should be updated as follows:

Measurement of Serum Biochemical Markers:

At the end of the cardiac function examination, rats were anesthetized with 1% pentobarbital sodium (50 mg/kg) by intraperitoneal injection, and blood samples were collected from the abdominal aorta and centrifuged at 1000 ×g for 20 min to obtain serum.Serum levels of ALD and PIIINP were measured by radioimmunoassay. BNP, ANP, MMP-2, and MMP-9 were detected by enzyme-linked immunosorbent assay following the instructions of kits (Fanke Biological Technology Company, Shanghai, China).